These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26754121)

  • 1. Urosepsis--Etiology, Diagnosis, and Treatment.
    Dreger NM; Degener S; Ahmad-Nejad P; Wöbker G; Roth S
    Dtsch Arztebl Int; 2015 Dec; 112(49):837-47; quiz 848. PubMed ID: 26754121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urosepsis. Current therapy and diagnosis].
    Book M; Lehmann LE; Schewe JC; Weber S; Stüber F
    Urologe A; 2005 Apr; 44(4):413-22; quiz 423-4. PubMed ID: 15776270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urosepsis: pathophysiology, diagnosis, and management-an update].
    Stangl F; Wagenlehner F; Schneidewind L; Kranz J
    Urologie; 2024 Jun; 63(6):543-550. PubMed ID: 38639782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management for urosepsis.
    Wagenlehner FM; Lichtenstern C; Rolfes C; Mayer K; Uhle F; Weidner W; Weigand MA
    Int J Urol; 2013 Oct; 20(10):963-70. PubMed ID: 23714209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management of urosepsis from the urological perspective.
    Wagenlehner FM; Weidner W; Naber KG
    Int J Antimicrob Agents; 2007 Nov; 30(5):390-7. PubMed ID: 17728107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.
    Wagenlehner FM; Weidner W; Naber KG
    Clin Pharmacokinet; 2007; 46(4):291-305. PubMed ID: 17375981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urosepsis: Overview of the Diagnostic and Treatment Challenges.
    Wagenlehner FME; Pilatz A; Weidner W; Naber KG
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urosepsis. Update on diagnosis and treatment].
    Wagenlehner FM; Alidjanov J; Pilatz A
    Urologe A; 2016 Apr; 55(4):454-9. PubMed ID: 27003569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urosepsis--from the view of the urologist.
    Wagenlehner FM; Pilatz A; Weidner W
    Int J Antimicrob Agents; 2011 Dec; 38 Suppl():51-7. PubMed ID: 21993485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic challenges of urosepsis.
    Wagenlehner FM; Pilatz A; Naber KG; Weidner W
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():45-9. PubMed ID: 18826481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Urosepsis in 2018.
    Bonkat G; Cai T; Veeratterapillay R; Bruyère F; Bartoletti R; Pilatz A; Köves B; Geerlings SE; Pradere B; Pickard R; Wagenlehner FME
    Eur Urol Focus; 2019 Jan; 5(1):5-9. PubMed ID: 30448051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infections and urosepsis: a physician's guide.
    Zeinati S; Khauli RB
    J Med Liban; 2004; 52(4):189-93. PubMed ID: 16432980
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on classification and management of urosepsis.
    Wagenlehner FM; Tandogdu Z; Bjerklund Johansen TE
    Curr Opin Urol; 2017 Mar; 27(2):133-137. PubMed ID: 27846034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urosepsis].
    Moen H; von der Lippe E; Tveter KJ
    Tidsskr Nor Laegeforen; 1997 Mar; 117(7):959-62. PubMed ID: 9103008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary tract infections in the critically ill patient with a urinary catheter.
    Rosser CJ; Bare RL; Meredith JW
    Am J Surg; 1999 Apr; 177(4):287-90. PubMed ID: 10326844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical symptoms in emergency department patients with urosepsis challenge current urinary tract infection management guidelines.
    Biebelberg B; Kehoe IE; Zheng H; O'Connell A; Filbin MR; Heldt T; Reisner AT
    Acad Emerg Med; 2024 Aug; 31(8):828-831. PubMed ID: 38661262
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urosepsis-targeted diagnostics and effective therapy].
    Kranz J; Stangl F; Kuppe C; Wagenlehner F; Saar M; Schneidewind L
    Urologie; 2022 Jun; 61(6):596-601. PubMed ID: 35522262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stone treatment after urosepsis in elderly or multimorbid patients--influence on sepsis recurrence rate and rehospitalisation].
    Stier K; Albrecht M; Cash H; Miller K; Fuller TF
    Aktuelle Urol; 2013 Nov; 44(6):456-61. PubMed ID: 24258397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical utility of measurement of procalcitonin for diagnosis of urosepsis].
    Hosokawa Y; Takenaga M; Itami Y; Shinohara M; Takada S; Hayashi Y; Hashimura M; Fujimoto K; Hirao Y
    Hinyokika Kiyo; 2012 Oct; 58(10):539-42. PubMed ID: 23235275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Study of the Etiology, Laboratory Findings, and Management of Patients with Urinary Tract Infections and Urosepsis from a Urology Center in Silesia, Southern Poland Between 2017 and 2020.
    Gofron ZF; Aptekorz M; Gibas KW; Kabała M; Martirosian G
    Med Sci Monit; 2022 Mar; 28():e935478. PubMed ID: 35332115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.